Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Qunling Zhang, Junning Cao, Kai Xue, Xiaojian Liu, Dongmei Ji, Ye Guo & Xiaonan Hong. (2017) Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma. OncoTargets and Therapy 10, pages 145-151.
Read now
Read now
Yudell Edelstein, Yevgeniy Margulis, Anthony D. Nicastri, William Solomon & Jaya Nath. (2006) Primary sellar lymphoma of T-cell type radiologic and pathologic findings. Leukemia & Lymphoma 47:6, pages 1166-1169.
Read now
Read now
Articles from other publishers (27)
Stefano Luminari & Tetiana Skrypets. (2021) What's new in peripheral T‐cell lymphomas. Hematological Oncology 39:S1, pages 52-60.
Crossref
Crossref
Jin-Hua Liang, Luo Lu, Hua-Yuan Zhu, Wang Li, Lei Fan, Jian-Yong Li & Wei Xu. (2019) The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH. Cancer Research and Treatment 51:1, pages 150-157.
Crossref
Crossref
Francesco d’Amore, Thomas Relander, Grete F. Lauritzsen, Esa Jantunen, Susanna Mannisto, Peter Meyer, Fredrik Ellin, Martin Bjerregård Pedersen & Helle Toldbod. 2017. Hematopoietic Cell Transplants. Hematopoietic Cell Transplants
428
435
.
. 2017. Hematopoietic Cell Transplants. Hematopoietic Cell Transplants
361
444
.
Anne W. Beaven & Louis F. Diehl. (2015) Peripheral T-cell lymphoma, NOS, and anaplastic large cell lymphoma. Hematology 2015:1, pages 550-558.
Crossref
Crossref
Luis Alberto de P?dua Covas Lage, Tamara Carvalho dos Santos Cabral, Renata de Oliveira Costa, Marianne de Castro Gon?alves, Debora Levy, Maria Cl?udia Nogueira Zerbini & Juliana Pereira. (2015) Primary nodal peripheral T-cell lymphomas: diagnosis and therapeutic considerations. Revista Brasileira de Hematologia e Hemoterapia 37:4, pages 277-284.
Crossref
Crossref
Owen A. O'Connor, Govind Bhagat, Karthik Ganapathi, Martin Bjerregaard Pedersen, Francesco D'Amore, Dejan Radeski & Susan E. Bates. (2014) Changing the Paradigms of Treatment in Peripheral T-cell Lymphoma: From Biology to Clinical Practice. Clinical Cancer Research 20:20, pages 5240-5254.
Crossref
Crossref
Eric Tse & Yok-Lam Kwong. (2011) Treatment algorithms for mature T-cell and natural killer-cell neoplasms. Future Oncology 7:9, pages 1101-1112.
Crossref
Crossref
Abeer N. AbouYabis, Pareen J. Shenoy, Rajni Sinha, Christopher R. Flowers & Mary Jo Lechowicz. (2011) A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma. ISRN Hematology 2011, pages 1-14.
Crossref
Crossref
Claire E. Dearden, Rod Johnson, Ruth Pettengell, Stephen Devereux, Kate Cwynarski, Sean Whittaker & Andrew McMillan. (2011) Guidelines for the management of mature T‐cell and NK‐cell neoplasms (excluding cutaneous T‐cell lymphoma). British Journal of Haematology 153:4, pages 451-485.
Crossref
Crossref
Thanyanan ReungwetwattanaSylvia JaramilloJulian R. Molina. (2011) Current and Emerging Therapies in Peripheral T-cell Lymphoma: Focus on Pralatrexate. Clinical Medicine Insights: Therapeutics 3, pages CMT.S3778.
Crossref
Crossref
Audrey Simon, Michel Peoch, Philippe Casassus, Eric Deconinck, Philippe Colombat, Bernard Desablens, Olivier Tournilhac, Houchingue Eghbali, Charles Foussard, Jerome Jaubert, Jean Pierre Vilque, Jean François Rossi, Virginie Lucas, Vincent Delwail, Antoine Thyss, Frederic Maloisel, Noel Milpied, Steven Le Gouill, Thierry Lamy & Rémy Gressin. (2010) Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95. British Journal of Haematology 151:2, pages 159-166.
Crossref
Crossref
Ian MagrathStefano Luminari & Massimo Federico. 2010. The Lymphoid Neoplasms 3ed. The Lymphoid Neoplasms 3ed
1400
1420
.
Laurence De Leval, Christian Gisselbrecht & Philippe Gaulard. (2010) Advances in the understanding and management of angioimmunoblastic T‐cell lymphoma. British Journal of Haematology 148:5, pages 673-689.
Crossref
Crossref
Delvys Rodriguez‐Abreu, Volmar Belisario Filho & Emanuele Zucca. (2007) Peripheral T‐cell lymphomas, unspecified (or not otherwise specified): a review. Hematological Oncology 26:1, pages 8-20.
Crossref
Crossref
Naoto Tomita, Shigeki Motomura, Rie Hyo, Hirotaka Takasaki, Sachiya Takemura, Jun Taguchi, Shin Fujisawa, Koji Ogawa, Yoshiaki Ishigatsubo & Kengo Takeuchi. (2007) Comparison of peripheral T‐cell lymphomas and diffuse large B‐cell lymphoma. Cancer 109:6, pages 1146-1151.
Crossref
Crossref
Jong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae, Dong Hwan Kim, Jin Ho Baek, Kyu Bo Lee, Je-Jung Lee, Ik-Joo Chung, Hyeoung-Joon Kim, Deok-Hwan Yang, Won-Sik Lee, Young-Don Joo & Chang-Hak Sohn. (2005) CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas. Cancer Chemotherapy and Pharmacology 58:1, pages 35-39.
Crossref
Crossref
Andrew M. Evens, Christiane Querfeld & Steven T. Rosen. 2006. Hodgkin’s and Non-Hodgkin’s Lymphoma. Hodgkin’s and Non-Hodgkin’s Lymphoma
161
220
.
Kerry J. Savage. (2005) Aggressive Peripheral T-Cell Lymphomas (Specified and Unspecified Types). Hematology 2005:1, pages 267-277.
Crossref
Crossref
K.J. Savage, M. Chhanabhai, R.D. Gascoyne & J.M. Connors. (2004) Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Annals of Oncology 15:10, pages 1467-1475.
Crossref
Crossref
Fortunato Morabito, Andrea Gallamini, Caterina Stelitano, Vincenzo Callea, Cesare Guglielmi, Santo Neri, Antonio Lazzaro, Lorella Orsucci, Fiorella Ilariucci, Stefano Sacchi, Umberto Vitolo & Massimo Federico. (2004) Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T‐cell lymphomas, unspecified, and 496 diffuse large B‐cell lymphomas. Cancer 101:7, pages 1601-1608.
Crossref
Crossref
Andrew M. Evens & Ronald B. Gartenhaus. (2004) Treatment of T-cell non-hodgkin’ lymphoma. Current Treatment Options in Oncology 5:4, pages 289-303.
Crossref
Crossref
Jong Gwang KimSang Kyun SohnDong Hwan KimJin Ho BaekTae In ParkKyu Bo Lee. (2004) Phase II Study of Cyclophosphamide, Epirubicin, Vincristine, Prednisone, and Etoposide (CEOP-E) for Aggressive Non-Hodgkin's Lymphoma. Journal of Korean Medical Science 19:6, pages 820.
Crossref
Crossref
Tanja BatinacGordana ZamoloNives JonjićFranjo GruberAntica NačinovićIrena Seili-Bekafigo & Miran Čoklo. (2018) Angioimmunoblastic Lymphadenopathy with Dysproteinemia following Doxycycline Administration. Tumori Journal 89:1, pages 91-95.
Crossref
Crossref
K Kim, W.S Kim, C.W Jung, Y.-H Im, W.K Kang, M.H Lee, C.H Park, Y.-H Ko, H.-J Ree & K Park. (2002) Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification. European Journal of Cancer 38:1, pages 75-81.
Crossref
Crossref
John P. Greer, Marsha C. Kinney & Thomas P. LoughranJr.Jr.. (2001) T Cell and NK Cell Lymphoproliferative Disorders. Hematology 2001:1, pages 259-281.
Crossref
Crossref
A. López-Guillermo, J. Cid, A. Salar, A. López, C. Montalbán, J.M. Castrillo, M. González, J.M. Ribera, S. Brunet, J. García-Conde, A. Fernández de Sevilla, F. Bosch & E. Montserrat. (1998) Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. Annals of Oncology 9:8, pages 849-855.
Crossref
Crossref